From professional translators, enterprises, web pages and freely available translation repositories.
fullnægjandi
injection steps
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nota skal fullnægjandi geislavarnir.
adequate shielding is mandatory.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ekki liggja fyrir fullnægjandi
insufficient data to recommend dosage
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Ónæmissvörun við fluarix var fullnægjandi.
the immune response to fluarix was satisfactory.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
mjög háan blóðþrýsting, án fullnægjandi meðferðar
very high blood pressure, not controlled by medical treatment
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nauðsynlegt er að vera í fullnægjandi hlífðarfötum.
adequate shielding is mandatory.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
fullnægjandi klínísk svörun eftir 7 daga?
satisfactory clinical response after 7 days?
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
fyrir sjúklinga á fullnægjandi meðferð með deferoxamini
for patients well managed on deferoxamine
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nauðsynlegt er að beita fullnægjandi smitsæfðum aðferðum.
appropriate aseptic techniques must be used.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lágmarkskröfur sem gerðar eru til fullnægjandi þjálfunarseturs eru:
minimum requirements for a qualified training centre are:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ef meðferðarsvörun er fullnægjandi eftir 7 daga, viðhaldsskammtur:
if full treatment response after 7 days, maintenance dose:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ekki liggja fyrir fullnægjandi gögn um lyfjahvörf hjá börnum.
there are insufficient pharmacokinetic data in paediatric patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ekki er víst að fullnægjandi ónæmissvörun komi fram hjá þessum einstaklingum.
in these individuals, an adequate immune response may not be elicited.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sjúklingar skulu fá fullnægjandi kalsíum- og d-vítamínuppbót.
patients should be adequately supplemented with calcium and vitamin d.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
engar fullnægjandi samanburðarrannsóknir hafa verið gerðar hjá þunguðum konum.
there are no adequate and well-controlled studies in pregnant women.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ekki liggja fyrir fullnægjandi klínískar upplýsingar um notkun á meðgöngu.
insufficient clinical data on exposed pregnancies are available.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ekki hafa verið gerðar fullnægjandi samanburðarrannsóknir með trametinibi hjá barnshafandi konum.
there are no adequate and well-controlled studies of trametinib in pregnant women.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ekki liggja fyrir neinar fullnægjandi rannsóknaniðurstöður um notkun anagrelíðs á meðgöngu.
there are no adequate data from the use of anagrelide in pregnant women.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
fullnægjandi inntaka kalks og d-vítamíns er mikilvæg fyrir alla sjúklinga.
adequate intake of calcium and vitamin d is important in all patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
engar fullnægjandi niðurstöður liggja fyrir varðandi notkun flútíkasónfúróats hjá þunguðum konum.
there are no adequate data from the use of fluticasone furoate in pregnant women.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: